Chimera Bioengineering is a biotech company whose mission is to reprogram life to end cancer using therapies that restore dignity to patients using safer and more potent next-generation CAR T therapeutics. Chimera solves the challenges of CARs with drug-responsive gene regulators which allow them to re-program the immune system.